Reconciling Opportunistic and Population Screening in Clinical Genomics.

Main|Search|PHGKB




Last Posted: Jan 09, 2019

---

• Reconciling Opportunistic and Population Screening in Clinical Genomics.
  Brothers Kyle B et al. Mayo Clinic proceedings 2019 Jan 94(1) 103-109
• Return of individual genomic research results: are laws and policies keeping step?
  A Thorogood et al, EJHG, January 8, 2019
• Ethical conundrums in pediatric genomics.
  Rotz Seth J et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 301-306
• The Burden of Candidate Pathogenic Variants for Kidney and Genitourinary Disorders Emerging From Exome Sequencing.
  Rasouly Hila Milo et al. Annals of internal medicine 2018 Nov
• [Performance of interpreting the variants of long QT syndrome according ACMG guidelines by four clinical gene screening agencies from Beijing].
  Liu N et al. Zhonghua xin xue guan bing za zhi 2018 Nov 46(11) 857-861
• Experiences and perspectives on the return of secondary findings among genetic epidemiologists
  CM Stein et al, Genetics in Medicine, November 23, 2018
• Wilson's Disease: A Review for the General Pediatrician.
  Capone Kristin et al. Pediatric annals 2018 Nov 47(11) e440-e444
• The preferences of potential stakeholders in psychiatric genomic research regarding consent procedures and information delivery.
  Sundby Anna et al. European psychiatry : the journal of the Association of European Psychiatrists 2018 Oct 5529-35
• Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
  Boardman Felicity et al. Molecular genetics & genomic medicine 2018 Oct
• Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.
  Slavin Thomas P et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Oct JCO1800328

more